Cathie Wood Entera Bio Ltd. Call Options Transaction History
Ark Investment Management LLC
- $14 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ENTX
# of Institutions
18Shares Held
4.27MCall Options Held
3.9KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL3.88MShares$6.37 Million4.05% of portfolio
-
Ubs Group Ag150KShares$245,7850.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny74.9KShares$122,8350.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA51.6KShares$84,6690.0% of portfolio
-
Virtu Financial LLC New York, NY22KShares$36,1450.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $47.2M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...